Preparation and characterization of luteinisinghormone releasing hormone nanoliposomal microbubbles specifically targeting ovarian cancer cells in vitro

Author：              

Publisher： Spandidos Publications

ISSN： 1791-2997

Source： Molecular Medicine Reports, Vol.10, Iss.1, 2014-01, pp. : 567-571

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

OSTP as a novel peptide specifically targeting human ovarian cancer

By          

Oncology Reports, Vol. 34, Iss. 2, 2015-01 ,pp. : 972-978

Spandidos Publications

Access to resources Recommend Favorite

Targeting Ovarian Cancer-Initiating Cells

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 2, 2010-02 ,pp. : 157-163

Bentham Science Publishers

Access to resources Recommend Favorite

Nanomolecular targeting of dendritic cells for ovarian cancer therapy

By Cubillos-Ruiz Juan R   Fiering Steven   Conejo-Garcia Jose R  

Future Oncology, Vol. 5, Iss. 8, 2009-10 ,pp. : 1189-1192

Future Medicine

Access to resources Recommend Favorite

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

By Garcia Agustin  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 45-46

Informa Healthcare

Access to resources Recommend Favorite

Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer

By Verschraegen C.F.   Westphalen S.   Hu W.   Loyer E.   Kudelka A.   Volker P.   Kavanagh J.   Steger M.   Schulz K.-D.   Emons G.  

Gynecologic Oncology, Vol. 90, Iss. 3, 2003-09 ,pp. : 552-559

Elsevier

Access to resources Recommend Favorite